References
Rao KRP, Patel AR, Anderson MJ, Hodgson J, Jones SE, Pattison JR: Infection with parvovirus-like virus and aplastic crisis in chronic hemolytic anemia. Ann Intern Med 98:930–932, 1983
Young N, Harrison M, Moore J, Mortimer P, Humphries RK: Direct demonstration of the human parvovirus in erythroid progenitor cells infectedin vitro. J Clin Invest 74:2024–2032, 1984
Young N, Mortimer P: Viruses and bone marrow failure. Blood 64:729–737, 1984
Wilson HA, McLaren GD, Dworken HJ, Tebbi K: Transient pure red-cell aplasia: Cell-mediated suppression of erythropoiesis associated with hepatitis. Ann Intern Med 92:196–198, 1980
Zeldis JB, Dienstag JL, Gale PR: Aplastic anemia and non-A, non-B hepatitis. Am J Med 74:64–68, 1983
Perrillo RP, Pohl DA, Roodman ST, Tsai CC: Acute non-A, non-B hepatitis with serum sickness-like syndrome and aplastic anemia. JAMA 245:494–496, 1981
Cargnel A, Vigano P, Davoli C, Morelli R, Perna MC, Mariscotti C: Sporadic acute non-A non-B hepatitis complicated by aplastic anemia. Am J Gastroenterol 78:245–247, 1983
Tzakis AG, Arditi M, Whitington PF, Yanaga K, Esquivel C, Andrews WA, Makowka L, Malatak L, Malatak J, Freese DK, Stock PG, Ascher NL, Johnsson FL, Broelsch CE, Starzl TE: Aplastic anemia complicating orthotopic liver transplantation for non-A, non-B hepatitis. N Engl J Med 319:393–396, 1988
Foon KA, Mitsuyasu RT, Schroff RW, McIntyre RE, Champlin R, Gale RP: Immunologic defects in young male patients with hepatitis-associated aplastic anemia. Ann Intern Med 100:657–662, 1984
Zoumbos NC, Djeu JY, Young NS: Interferon is the suppressor of hematopoiesis generated by stimulated lymphocytesin vitro. J Immunol 133:769–774, 1984
Zoumbos NC, Gascon P, Djeu JY, Trost SR, Young NS: Circulating activating suppressor T lymphocytes in aplastic anemia. N Engl J Med 312:257–265, 1985
Gascon P, Zoumbos NC, Scala G, Djeu JY, Moore JG, Young NS: Lymphokine abnormalities in aplastic anemia: Implications for the mechanisms of action of antithymocyte globulin. Blood 65:407–413, 1985
Zoumbos N, Gascon P, Djeu J, Young N: Interferon is a mediator of hematopoeitic suppression in aplastic anemiain vitro and possiblyin vivo. Proc Natl Acad Sci USA 82:188–192, 1985
Herrmann F, Griffin JD, Meuer SG, Meyer zum Büschenfelde KH: Establishment of an interleukin 2-dependent T cell line derived from a patient with severe aplastic anemia, which inhibitsin vitro hematopoiesis. J Immunol 136:1629–1634, 1986
Nisticò A, Young NS: Gamma-interferon gene expression in the bone marrow of patients with aplastic anemia. Ann Intern Med 120:643–649, 1994
Goergen B, Jakobs S, Symmons P, Hornes E, Meyer zum Büschenfelde KH, Gerken G: Quantitation of HCV-replication using one-step competitive RT-PCR and a solid phase, colorimetric detection method. J Hepatol 21:678–682; 1994
Féray C, Samuel D, Thiers V, Gigon M, Pichau F, Bismuth A, Reynes M, Maisonneuve P, Bismuth H, Bréchot C: Reinfection of liver graft by hepatitis C virus after liver transplantation. J Clin Invest 89:1361–1365, 1992
Zaaijer HL, Cuypers HTM, Reesink HW, Winkel IN, Gerken G, Lelie PN: Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 341:722–724, 1993
Fong TL, Shindo M, Feinstone SM, Hoofnagle JH, Di Bisceglie AM: Detection of replicative intermediates of hepatitis C viral RNA in liver and serum of patients with chronic hepatitis C. J Clin Invest 88:1058–1060, 1991
Takehara T, Hayashi N, Mita E, Hagiwara H, Ueda K, Katayama K, Kasahara A, Fusamoto H, Kamada T: Detection of the minus strand of hepatitis C virus RNA by reverse transcription and polymerase chain reaction: Implication for hepatitis C virus replication in infected tissue. Hepatology 15:387–390, 1992
Wang JT, Sheu JC, Lin JT, Wang TH, Chen DS: Detection of replicative forms of hepatitis C virus RNA in peripheral blood mononuclear cells. J Infect Dis 166:1167–1169, 1992
Miltenyi S, Müller W, Weichel W, Radbruch A: High gradient magnetic cell separation with MACS. Cytometry 11:231–238, 1990
Simmonds P, McOrnish F, Yap PL, Chan SW, Lin CK, Dusheiko G, Saeed AA, Holmes EC: Sequence variability in the 5′ non-coding region of hepatitis C virus: Identification of a new virus type and restrictions on sequence diversity. J Gen Virol 74:661–668, 1993
Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborght B, van Heuverswyn H, Maertens G: Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 74:1105–1113, 1993
Manns M, Meyer zum Büschenfelde KH, Slusarszyk J, Dienes HP: Detection of liver-kidney microsomal autoantibodies by radioimmunoassay and their relation to antimitochandrial antibodies in inflammatory liver diseases. Clin Exp Immunol 57:600–608, 1984
Manns M, Gerken G, Kyriatsoulis A, Staritz M, Meyer zum Büschenfelde KH: Characterization of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen. Lancet 1:292–294, 1987
Manns MP, Johnson EF, Griffin KJ, Tan EM, Sullivan KF: Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1. J Clin Invest 83:1066–1072, 1989
Treichel U, Poralla T, Hess G, Manns M, Meyer zum Büschenfelde KH: Autoantibodies to human asialoglycoprotein receptor in autoimmune-type chronic hepatitis. Hepatology 11:606–612, 1990
Michel G, Ritter A, Gerken G, Meyer zum Büschenfelde KH, Decker R, Manns MP: Anti-GOR and hepatitis C virus in autoimmune liver diseases. Lancet 339:267–269, 1992
Frickhofen N, Kaltwasser JP, Schrezenmeier H, Raghavachar A, Vogt HG, Herrmann F, Freund M, Meusers P, Salama A, Heimpel H: Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. N Engl J Med 324:1297–1304, 1991
Camitta BM, Thomas ED, Nathan DG, Gale RP, Kopecky KJ, Rappeport JM, Santos G, Gordon-Smith EC, Storb R: A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood 53:504–514, 1979
Hinterberger-Fischer M, Hinterberger W, Hoeckern P: Treatment of severe aplastic anemia with combined immunosuppression. Acta Haematol 76:196–201, 1986
Young N, Griffith P, Brittain E, Elfenbein G, Gardner F, Huang A, Harmon D, Hewlett J, Fay J, Mangan K, Morrison F, Sensenbrenner L, Shadduck R, Wang W, Zaroulis C, Zuckerman K: A multicenter trial of antithymocyte globulin in aplastic anemia and related diseases. Blood 72:1861–1869, 1988
Gluckman E: Current status of bone marrow transplantation for severe aplastic anemia: A preliminary report from the International Bone Marrow Transplant Registry. Transplant Proc 19:2597–2599, 1987
Klingemann HG, Storb R, Fefer A: Bone marrow transplantation in patients aged 45 years and older. Blood 67:770–776, 1986
Hunter RF, Mold NG, Mitchell RB, Huang AT: Differentiation of normal marrow and HL60 cells induced by antithymocyte globulin. Proc Natl Acad Sci USA 82:4823–4827, 1985
Kawano Y, Nissen C, Gratwohl A, Speck B: Immunostimulatory effects of different antilymphocyte globulin preparations: A possible clue to their clinical effect. Br J Haematol 68:115–119, 1988
Stryckmans PA, Dumont JP, Velu T, Debusscher L: Cyclosporine in refractory severe aplastic anemia. N Engl J Med 310:655–656, 1984
Frickhofen N, Heit W, Raghavachar A, Porzolt F, Heimpel H: Treatment of aplastic anemia with cyclosporine A, methylprednisolone, and antithymocyte globulin. Klin Wochenschr 64:1165–1170, 1986
Pol S, Thiers V, Driss F, Devergie A, Berthelot P, Bréchot C, Gluckman E: Lack of evidence for a role of HCV in hepatitis-associated aplastic anemia. Br J Haematol 85:808–810, 1993
Hibbs JR, Frickhofen N, Rosenfeld SJ, Feinstone SM, Kojima S, Bacigalupo A, Locasciulli A, Tzakis AG, Alter HJ, Young NS: Aplastic anemia and viral hepatitis. Non-A, non-B, non-C? JAMA 267:2051–2054, 1992
McGuinness PH, Bishop GA, McCaughan GW, Trowbridge R, Gowans EJ: False detection of negative-strand of hepatitis C virus RNA. Lancet 343:551–552, 1994
Fong T-L, Shindo M, Feinstone SM, Hoofnagle JH, De Bisceglie AM: Detection of replicative intermediates of hepatitis C viral RNA in liver and serum of patients with chronic hepatitis C. J Clin Invest 88:1058–1060, 1991
Müller HM, Kalliniowski B, Solbach C, Theilmann L, Goeser T, Pfaff E: B-lymphocytes are predominantly involved in viral propagation of hepatitis C virus (HCV). Arch Virol suppl 9:307–316, 1994
Lenzi M, Johnson PJ, McFarlane IG, Ballardini G, Smith HM, McFarlane BM, Bridger C, Vergani D, Bianchi FB, Williams R: Antibodies to hepatitis C virus in autoimmune liver disease; evidence for geographical heterogeneity. Lancet 338:1370–1378, 1991
Lunel F, Abuaf N, Frangeul L, Grippon P, Perrin M, Le Coz Y, Valla D, Yamamoto A-M, Huraux J-M, Opolon P, Homberg J-C: Liver/kidney microsome antibody type 1 and hepatitis C virus infection. Hepatology 16:630–636, 1992
Vergani D, Mieli-Vergani G: Type II autoimmune hepatitis: What is the role of hepatitis C virus? Gastroenterology 104:1870–1873, 1993
Manns MP, Griffin KJ, Sullivan KF, Johnson EF: LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase. J Clin Invest 88:1370–1378, 1991
Homberg JC, Abuaf N, Bernard O, Islam S, Alvarez F, Khalil SH, Poupon R, Darnis F, Levy V-G, Grippon P, Opolon P, Bernuau J, Benhamou J-P, Alagille D: Chronic active hepatitis associated with anti-liver/kidney microsome autoantibody type I: A second type of “autoimmune hepatitis.” Hepatology 7:1333–1339, 1987
Seki T, Kiyosawa K, Inoko H, Ota M: Association of autoimmune hepatitis with HLA BW 54 and DR 4 in Japanese patients. Hepatology 12:1300–1304, 1990
Manns M, Scheucher S, Jenisch, Broly F, Goergen B, Schneider P, Gerken G, Rittner C, Meyer zum Büschenfelde KH, Meyer U: Genetics in autoimmune hepatitis type 2. Hepatology 14:60A, 1991
Ferri C, Greco F, Longombardo G, Palla P, Moretti A, Marzo E, Fosella PV, Pasero G, Bondardieri S: Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia. Arthritis Rheum 34:1606–1610, 1991
Lunel F, Musset L, Cacoub P: Prevalence of mixed cryoglobulinemia in 112 patients with viral and non viral chronic hepatitis or cirrhosis. J Hepatol 16:13–20, 1992
Agnello V, Chung RT, Kaplan L: A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 327:1490–1496, 1992
Cacoub P, Lunel Fabiani F, Musset L, Frangeul L, Leger JM, Huraux J-M, Piette J-C, Godeau P: Mixed cryoglobulinemia and hepatitis C virus. Am J Med 96:124–132, 1994
Misiani R, Bellavita P, Fenili D, Vicari O, Marchesi D, Sironi PL, Zilio P, Vernocchi A, Massazza M, Venramin G, Tanzi E, Zanetti A: Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 330:751–756, 1994
Bloch KJ: Cryoglobulinemia and hepatitis C virus. N Engl J Med 327:1521–1523, 1992
Gabrielli A, Manzin A, Candela M, Caniglia ML, Paolucci S, Danieli MG, Clementi M: Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglobulinemia. Clin Exp Immunol 97:87–93, 1994
Schlaak JF, Löhr H, Gallati H, Meyer zum Büschenfelde KH, Fleischer B: Analysis ofin vitro cytokine production by liver-infiltrating T cells of patients with autoimmune hepatitis. Clin Exp Immunol 94:168–173, 1993
Löhr HF, Schlaak JF, Gerken G, Fleischer B, Dienes HP, Meyer zum Büschenfelde KH: Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of different etiology. Liver 14:161–166, 1994
Author information
Authors and Affiliations
Additional information
This work was supported by the Deutsche Forschungsgemeinschaft (SFB 311; project A-13).
Rights and permissions
About this article
Cite this article
Peters, M., Trippler, M., Löhr, H. et al. Posttransfusional, LKM-1-autoantibody-positive hepatitis C virus infection, cryoglobulinemia, and aplastic anemia. Digest Dis Sci 40, 763–773 (1995). https://doi.org/10.1007/BF02064977
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02064977